Veeva was founded in 2007 by Peter Gassner and Matt Wallach to make life sciences more efficient and bring new medicines to patients. The company is one of the most important case studies on how to build a standalone software business in life sciences.
Veeva was founded in 2007 by Peter Gassner and Matt Wallach to make life sciences more efficient and bring new medicines to patients. The company is one of the most important case studies on how to build a standalone software business in life sciences.
- Rita Levi-Montalcini, Nobel Prize winner for discovering nerve growth factor
- Rita Levi-Montalcini, Nobel Prize winner for discovering nerve growth factor
- Joshua Boger, Founder & CEO of Vertex Pharmaceuticals
- Joshua Boger, Founder & CEO of Vertex Pharmaceuticals
Applying Bayesian optimization to the problem of HTS by constructing a surrogate model of the docking score of a ligand for a given protein target
Applying Bayesian optimization to the problem of HTS by constructing a surrogate model of the docking score of a ligand for a given protein target
With 2 approaches, the paper estimates that there are approximately 30 HSC clones that arise during development in zebrafish. Similar to estimates in other animals
With 2 approaches, the paper estimates that there are approximately 30 HSC clones that arise during development in zebrafish. Similar to estimates in other animals
The paper studies how phosphorylation of proteins affects the reactivity of cysteine residues
The paper studies how phosphorylation of proteins affects the reactivity of cysteine residues
Describes a new method for sorting cells based on their physical properties. Using a combination of real-time deformability cytometry (RT-DC) and focused travelling surface acoustic waves (FTSAW).
pubs.rsc.org/en/content/a...
Describes a new method for sorting cells based on their physical properties. Using a combination of real-time deformability cytometry (RT-DC) and focused travelling surface acoustic waves (FTSAW).
pubs.rsc.org/en/content/a...
- David MacMillan, Nobel Prize winner for developing asymmetric organocatalysis
- David MacMillan, Nobel Prize winner for developing asymmetric organocatalysis